Want to see SE:PTRK full AI Analyst Report?

Physitrack Limited (PTRK) Price & Analysis

1 Followers

PTRK Stock Chart & Stats

kr13.15

kr0.20(1.54%)

At close: Mar 06 4:00 PM EST

kr13.15

kr0.20(1.54%)

Day’s Range― - ―

52-Week Rangekr7.36 - kr21.70

Previous CloseN/A

Volume8.48K

Average Volume (3M)49.62K

Market Cap

kr131.06M

Enterprise Valuekr168.38

Total Cash (Recent Filing)kr398.16K

Total Debt (Recent Filing)kr4.28M

Price to Earnings (P/E)―

Beta0.66

Next Earnings

Oct 20, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.51

Shares Outstanding16,260,765

10 Day Avg. Volume41,844

30 Day Avg. Volume49,617

Financial Highlights & Ratios

PEG Ratio-0.57

Price to Book (P/B)1.97

Price to Sales (P/S)1.42

P/FCF Ratio5.09

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)kr13.80M

Bulls Say, Bears Say

Bulls Say

Recurring Subscription ModelA subscription-based SaaS model generates recurring, predictable revenue and supports customer retention and upsell to clinics or enterprises. Over months this underpins cash visibility, scalable unit economics and margin expansion potential as fixed costs are leveraged across a growing user base.

Positive Operating & Free Cash FlowConsistent positive operating and free cash flow despite net losses indicates strong cash conversion and operational discipline. This cash generation reduces near-term refinancing risk, funds product development or sales efforts, and provides runway to execute strategic recovery over the next several quarters.

Manageable Leverage And Positive EBITDAA moderate debt load and positive EBITDA margin show the business can produce operating profits and has balance-sheet flexibility. This combination supports funding of growth initiatives and cushions against cyclicality while management works to translate operating gains into net profitability.

Bears Say

Sharp TTM Revenue DeclineA ~90% TTM revenue collapse is a structural red flag: it erodes scale economics, undermines pricing power and weakens customer momentum. If sustained, the shrinking revenue base limits ability to invest in product, retain talent, and recover margins across the 2–6 month horizon.

Large Net Losses And Negative MarginsDeep negative net margins signal the company is not converting operating activity to bottom-line profitability. Persistent losses destroy equity, constrain reinvestment and may force dilutive financing or cost-cutting that hamper growth and long-term competitiveness.

Negative ROE And Shrinking Asset BaseStrongly negative ROE and a contracting balance sheet indicate shareholder value destruction and potential retrenchment. Reduced assets can reflect cutbacks in R&D or sales capacity, weakening the product roadmap and market position over several quarters unless reversed.

PTRK FAQ

What was Physitrack Limited’s price range in the past 12 months?

Physitrack Limited lowest stock price was kr7.36 and its highest was kr21.70 in the past 12 months.

What is Physitrack Limited’s market cap?

Physitrack Limited’s market cap is kr131.06M.

When is Physitrack Limited’s upcoming earnings report date?

Physitrack Limited’s upcoming earnings report date is Oct 20, 2026 which is in 85 days.

How were Physitrack Limited’s earnings last quarter?

Physitrack Limited released its earnings results on Jul 21, 2026. The company reported -kr0.11 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Physitrack Limited overvalued?

According to Wall Street analysts Physitrack Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Physitrack Limited pay dividends?

Physitrack Limited does not currently pay dividends.

What is Physitrack Limited’s EPS estimate?

Physitrack Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Physitrack Limited have?

Physitrack Limited has 16,260,765 shares outstanding.

What happened to Physitrack Limited’s price movement after its last earnings report?

Physitrack Limited reported an EPS of -kr0.11 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 10.283%.

Which hedge fund is a major shareholder of Physitrack Limited?

Currently, no hedge funds are holding shares in SE:PTRK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Physitrack Limited

Physitrack PLC operates globally as a digital healthcare innovator. The company delivers a proprietary cloud-based Software-as-a-Service (SaaS) platform, utilized by a diverse range of healthcare providers, from individual practitioners to large organizations, to completely digitalize the patient journey—from their initial contact through ongoing interactions and tracking of progress. Additionally, Physitrack offers virtual care solutions that address three key areas for patients and insurance plan members: preventive and wellness support, care for acute and chronic conditions, and surgical recovery. These virtual care services are supplied to healthcare enterprises such as private and public hospitals, clinics, and other health businesses. Founded in 2012, the company was formerly known as Physitrack Limited before rebranding to Physitrack PLC in May 2021 and is based in London, United Kingdom.